From a Cup of Tea to Cardiovascular Care: Vascular Mechanisms of Action.

blood pressure blood sugar cardiovascular health lipid profile polyphenols tea vascular

Journal

Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444

Informations de publication

Date de publication:
15 Sep 2024
Historique:
received: 19 07 2024
revised: 10 09 2024
accepted: 12 09 2024
medline: 28 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

Tea consumption is increasingly recognized for its potential benefits to cardiovascular health. This study reviews the available research, concentrating on the major components of tea and their mechanisms of action in the cardiovascular system. Tea is abundant in bioactive compounds, such as flavonoids and polysaccharides, which possess significant antioxidant and anti-inflammatory properties. These compounds play a crucial role in mitigating oxidative stress and inflammation, thereby supporting cardiovascular health. They enhance endothelial function, leading to improved vascular relaxation and reduced arterial stiffness, and exhibit antithrombotic effects. Additionally, regular tea consumption is potentially associated with better regulation of blood pressure, improved cholesterol profiles, and effective blood sugar control. It has been suggested that incorporating tea into daily dietary habits could be a practical strategy for cardiovascular disease prevention and management. Despite the promising evidence, more rigorous clinical trials are needed to establish standardized consumption recommendations and fully understand long-term effects. This review offers a more comprehensive analysis of the current evidence based on endothelium function and identifies the gaps that future research should address.

Identifiants

pubmed: 39337950
pii: life14091168
doi: 10.3390/life14091168
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Auteurs

Marios Sagris (M)

Hippokration General Hospital, School of Medicine, National and Kapodistrian University of Athens, 15772 Athens, Greece.

Panayotis K Vlachakis (PK)

Hippokration General Hospital, School of Medicine, National and Kapodistrian University of Athens, 15772 Athens, Greece.

Spyridon Simantiris (S)

Hippokration General Hospital, School of Medicine, National and Kapodistrian University of Athens, 15772 Athens, Greece.

Panagiotis Theofilis (P)

Hippokration General Hospital, School of Medicine, National and Kapodistrian University of Athens, 15772 Athens, Greece.

Maria Gerogianni (M)

Endocrine Unit, 2nd Propaedeutic Department of Internal Medicine, School of Medicine, Research Institute and Diabetes Center, Attikon University Hospital, National and Kapodistrian University of Athens, 12641 Athens, Greece.

Paschalis Karakasis (P)

Second Department of Cardiology, Aristotle University of Thessaloniki, General Hospital Hippokration, 54942 Thessaloniki, Greece.

Konstantinos Tsioufis (K)

Hippokration General Hospital, School of Medicine, National and Kapodistrian University of Athens, 15772 Athens, Greece.

Dimitris Tousoulis (D)

Hippokration General Hospital, School of Medicine, National and Kapodistrian University of Athens, 15772 Athens, Greece.

Classifications MeSH